Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Conclusions<br />
• No overall difference for Primary Outcome<br />
• Suggestive benefit of warfar<strong>in</strong> for Primary<br />
Outcome at 4 years and beyond<br />
• <strong>Warfar<strong>in</strong></strong> reduces ischemic stroke risk<br />
throughout follow-up<br />
• More major hemorrhage with warfar<strong>in</strong>, but<br />
<strong>in</strong>tracerebral and <strong>in</strong>tracranial hemorrhage similar<br />
• No difference for the Ma<strong>in</strong> Secondary Outcome<br />
(Primary Outcome + MI and HFH)
Change language